Research & Evidence

Pavis GF et al. (2024) A four-week dietary intervention with mycoprotein-containing food products reduces serum cholesterol concentrations in community-dwelling, overweight adults: a randomised controlled trial

Clin Nutr, e-pub ahead of print. Total, LDL and non-HDL cholesterol concentrations decreased by 5%, 10% and 6%, respectively, in the mycoprotein intervention arm, and lower blood glucose and c-peptide concentrations are also reported.

View

Shahid M et al. (2023) The effect of mycoprotein intake on biomarkers of human health: a systematic review and meta-analysis

Am J Clin Nutr, 118(1):141-150. This study showed that consuming mycoprotein in place of animal or plant-sources may have important effects on total cholesterol, an established predictor of cardiovascular disease.

View

Gibbs J and Leung GK (2023) The Effect of Plant-Based and Mycoprotein-Based Meat Substitute Consumption on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Controlled Intervention Trials

Dietetics, 2(1):104-122. Pooled analyses from the 12 studies suggest the replacement of some or all meat with plant-based or mycoprotein-based substitutes may lower total and LDL cholesterol, and triglycerides.

View

Iqbal S et al. (2022) A Systematic Review of Human Trials on Mycoprotein - Way towards a Sustainable Ecosystem

Cell Mol Biol, 68(12):5-11. This review explores the literature reporting on effects of mycoprotein on health markers including cholesterol, glycaemic response, uric acid concentrations and gut health.

View

Coelho MOC et al. (2020) Short-Communication: Ingestion of a Nucleotide-Rich Mixed Meal Increases Serum Uric Acid Concentrations but Does Not Affect Postprandial Blood Glucose or Serum Insulin Responses in Young Adults.

Nutrients, 12(4):1115. This randomised-controlled trial investigated the effects of a mixed meal with either nucleotide-depleted or high-nucleotide mycoprotein on postprandial circulating uric acid, glucose and insulin responses.

View

Coelho MOC et al. (2020) Mycoprotein as a possible alternative source of dietary protein to support muscle and metabolic health

Nutr Rev, 78(6):486-497. This review highlights mycoprotein as a sustainable, nutrient-rich protein source, with positive impacts on metabolic health, and potential for muscle adaption or maintenance.

View

Coelho MOC et al. (2020) Daily mycoprotein consumption for 1 week does not affect insulin sensitivity or glycaemic control but modulates the plasma lipidome in healthy adults: a randomised controlled trial

Brit J Nutr, 125(2):147-160. Substituting meat/fish for mycoprotein twice daily resulted in a decrease in total, LDL and HDL2 cholesterol concentrations but there were no changes in glycaemic control or insulin sensitivity.

View

Cherta-Murillo A et al. (2020) Effects of mycoprotein on glycaemic control and energy intake in humans: a systematic review

Brit J Nutr, 123(12):1321-1332. The acute ingestion of mycoprotein reduced energy intake and insulinaemia, but its impact on glycaemia is currently unclear.

View

Dunlop MV et al. (2017) Mycoprotein represents a bioavailable and insulinotropic non-animal-derived dietary protein source: a dose-response study

Brit J Nutr, 118(9):673-685. The bioavailability of amino acids and insulin responses to mycoprotein, compared to milk protein, suggest it may be a useful source of dietary protein to stimulate muscle protein synthesis.

View

Bottin JH et al. (2016) Mycoprotein reduces energy intake and postprandial insulin release without altering GLP1 and PYY concentrations in healthy overweight and obese adults: a randomised-controlled trial

Brit J Nutr, 116(2):360-374. Mycoprotein reduced energy intake and postprandial insulin release without altering GLP-1 and PYY concentrations in healthy overweight and obese adults.

View